Stay updated on Safety of Anti-tumor Drug in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Safety of Anti-tumor Drug in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Safety of Anti-tumor Drug in Advanced Solid Tumors Clinical Trial page
- Check4 days agoChange DetectedA new revision entry, v3.6.4, appears in the record history, updating the previously listed revision. This seems to reflect a platform or UI update and does not affect the study details shown on the page.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe record history shows a new revision entry: v3.6.3 replacing the previous v3.6.2. This reflects a platform update rather than a change to the trial data.SummaryDifference0.1%

- Check32 days agoChange DetectedA new revision entry v3.6.2 was added to the record history and the previous v3.6.0 entry was removed, indicating an update to the study's revision log.SummaryDifference0.1%

- Check46 days agoChange DetectedThe record history shows a new recruitment status 'No longer looking for participants' along with the addition of a new revision note (v3.6.0) and the deletion of the previous revision note (v3.5.5).SummaryDifference0.4%

- Check53 days agoChange DetectedA new revision entry (Revision: v3.5.5) is added to the study record history, and the prior revision (Revision: v3.5.4) is removed from the visible history. This updates the page's historical trail without changing the underlying study data.SummaryDifference0.1%

- Check75 days agoChange DetectedThe revision in the page history updates from v3.5.3 to v3.5.4, indicating a platform release rather than changes to study content.SummaryDifference0.1%

Stay in the know with updates to Safety of Anti-tumor Drug in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Anti-tumor Drug in Advanced Solid Tumors Clinical Trial page.